LGC Biosearch Technologies A/S: Financial statements 2013
CVR: 34884900
Source: annual report 2013, Danish Business Authority
01/12/2012 – 31/12/2013
LGC Biosearch Technologies A/S (CVR 34884900) has filed annual accounts for 2013. In 2013, the company reported a gross profit of DKK 4,498,044 and a net result of DKK -1,198,054. Equity in the 2013 report amounted to DKK 15,257,810. The solvency ratio was 93.3%.
- Gross Profit
- DKK 4,498,044
- Profit/Loss
- DKK -1,198,054
- Equity
- DKK 15,257,810
- Total Assets
- DKK 16,361,369
Official annual report
Fetch this data via API
Every Danish company, financial statement and ownership record, straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2013
As of September 18, 2013, RSM PLUS P/S STATSAUTORISEREDE REVISORER has been appointed auditor of LGC Biosearch Technologies A/S.
As of September 18, 2013, RSM PLUS P/S STATSAUTORISEREDE REVISORER has stepped down as auditor of LGC Biosearch Technologies A/S.
About LGC Biosearch Technologies A/S
LGC Biosearch Technologies A/S is a Danish company of the type Aktieselskab based in Lystrup, founded in 2012. The company is registered under the industry Fremstilling af andre kemiske produkter i.a.n.. The company was previously named DNA TECHNOLOGY A/S and BIOSEARCH TECHNOLOGIES DENMARK A/S. The management consists of Daren Dick. The board consists of Henrik Daugård (chair), Bettina Kecskes and Daren Dick. The company is owned by Biosearch Technologies, Inc.. The company has 47 employees (2026). In 2026, the company reported revenue of DKK 106,677,751 and a net result of DKK 8,198,725 compared with DKK 11,805,577 the year before. Equity in the 2026 report amounted to DKK 88,072,722.